Hal Allergy Groupfounded In 1959 In Haarlemthe Netherlandsis A Prominent European Company Specializing In Allergy Immunotherapyinitially Established To Provide Allergen Extracts To Local Practitionersthe Company Has Grown Significantlyexpanding Its Operations And Exporting To Germany Since The 1970Sin 2007Hal Allergy Moved To The Bio Science Park In Leiden To Enhance Its Production Capabilities And Launched Halix In 2012Focusing On Contract Manufacturing For Biotechnological Products The Company Offers A Wide Range Of Subcutaneousscitand Sublingualslitimmunotherapy Products Aimed At Treating Allergies From Pollenhouse Dust Mitesand Insect Venomshal Allergy Is Known For Its Modified Allergen Extracts Used In Therapeutic And Diagnostic Applicationssupported By State Of The Art Gmp Certified Production Facilitieswith A Commitment To Innovationhal Allergy Collaborates With Healthcare Professionals Across Europe And Partners With Technology Providers To Improve Operational Efficiencythe Company Reported An Annual Revenue Of $61 1 Million And Employs Around 269 People
